Medicare Enrolled
Dr. Ashish Khot, MD
Hematology & Oncology · Springfield, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Khot from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Khot?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Khot
Dr. Ashish Khot is a hematology & oncology specialist in Springfield, NJ, with 16 years of NPI registration. Based on federal Medicare data, Dr. Khot performed 1,780 Medicare services across 1,133 unique beneficiaries.
Between the years covered by Open Payments, Dr. Khot received a total of $77,093 from 82 pharmaceutical and/or device companies across 657 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Khot is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 50% volume in NJ
$77,093 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,780
Medicare services
Top 50% in NJ for hematology & oncology
1,133
Unique beneficiaries
$109
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~111 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
566 | $77 | $247 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
408 | $150 | $488 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
354 | $106 | $363 |
| New patient office visit, complex (60-74 min) | 140 | $188 | $691 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
66 | $148 | $733 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
64 | $68 | $240 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
58 | $102 | $343 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
41 | $50 | $150 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
30 | $13 | $72 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
29 | $1 | $10 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $108 | $449 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$77,093
Total received (2018-2024)
Avg $11,013/year across 7 years
Top 5% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
82
Companies
657
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$66,873 (86.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,721 (11.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,472 (1.9%)
Other
Charitable contributions, space rental, and other categories
$28 (0.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$22,751
2023
$38,411
2022
$9,652
2021
$992
2020
$1,060
2019
$2,370
2018
$1,858
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PFIZER INC.
$8,835
Astellas Pharma US Inc
$4,447
Exelixis Inc.
$4,390
Merck Sharp & Dohme LLC
$3,998
Ferring Pharmaceuticals Inc.
$158
Pharmacosmos Therapeutics Inc.
$142
Medtronic, Inc.
$136
Novartis Pharmaceuticals Corporation
$68
BeiGene USA, Inc.
$63
Daiichi Sankyo Inc.
$48
Mirati Therapeutics, Inc.
$47
ABBVIE INC.
$45
TAIHO ONCOLOGY, INC.
$41
Incyte Corporation
$41
E.R. Squibb & Sons, L.L.C.
$36
Celgene Corporation
$34
ADC Therapeutics America, Inc.
$29
ARRAY BIOPHARMA INC
$27
Bayer Healthcare Pharmaceuticals Inc.
$26
SpringWorks Therapeutics, Inc.
$21
bluebird bio, Inc.
$20
Eisai Inc.
$19
EMD Serono, Inc.
$17
Sumitomo Pharma America, Inc.
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Genentech USA, Inc.
$15
SERVIER PHARMACEUTICALS LLC
$15
Top 3 companies account for 77.7% of 2024 payments
All-time payments by company (2018-2024) ›
Exelixis Inc.
$30,469
Astellas Pharma US Inc
$12,753
Merck Sharp & Dohme LLC
$10,665
PFIZER INC.
$9,203
Seagen Inc.
$4,009
Incyte Corporation
$1,709
Novartis Pharmaceuticals Corporation
$765
Janssen Biotech, Inc.
$675
GENZYME CORPORATION
$657
AstraZeneca Pharmaceuticals LP
$511
Merck Sharp & Dohme Corporation
$382
E.R. Squibb & Sons, L.L.C.
$374
Amgen Inc.
$343
Genentech USA, Inc.
$340
Daiichi Sankyo Inc.
$188
Bayer HealthCare Pharmaceuticals Inc.
$173
Regeneron Healthcare Solutions, Inc.
$173
Celgene Corporation
$171
Janssen Pharmaceuticals, Inc
$169
Ferring Pharmaceuticals Inc.
$158
Takeda Pharmaceuticals U.S.A., Inc.
$157
Mirati Therapeutics, Inc.
$156
Pharmacosmos Therapeutics Inc.
$142
Medtronic, Inc.
$136
Eisai Inc.
$136
AVEO Pharmaceuticals, Inc.
$131
Boehringer Ingelheim Pharmaceuticals, Inc.
$113
Alexion Pharmaceuticals, Inc.
$105
Lilly USA, LLC
$104
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$104
Myovant Sciences Inc.
$97
SANOFI-AVENTIS U.S. LLC
$85
EMD Serono, Inc.
$84
Bayer Healthcare Pharmaceuticals Inc.
$80
Sirtex Medical Inc
$74
Foundation Medicine, Inc.
$67
BeiGene USA, Inc.
$63
MEDIVATION FIELD SOLUTIONS LLC
$62
ARRAY BIOPHARMA INC
$60
Taiho Oncology, Inc.
$58
Rigel Pharmaceuticals, Inc.
$57
TESARO, Inc.
$56
Pharmacyclics LLC, An AbbVie Company
$56
EISAI INC.
$54
ABBVIE INC.
$45
JAZZ PHARMACEUTICALS INC.
$45
Karyopharm Therapeutics Inc.
$45
MorphoSys, US Inc.
$44
Blueprint Medicines Corporation
$44
Dendreon Pharmaceuticals LLC
$43
Otsuka America Pharmaceutical, Inc.
$42
TAIHO ONCOLOGY, INC.
$41
Ipsen Biopharmaceuticals, Inc
$40
Janssen Scientific Affairs, LLC
$33
Sumitomo Pharma America, Inc.
$31
SERVIER PHARMACEUTICALS LLC
$30
Global Blood Therapeutics, Inc.
$29
ADC Therapeutics America, Inc.
$29
EUSA Pharma (US) LLC
$28
Jazz Pharmaceuticals Inc.
$28
Epizyme, Inc.,
$28
Gilead Sciences, Inc.
$27
AMAG Pharmaceuticals, Inc.
$25
AbbVie Inc.
$25
Seattle Genetics, Inc.
$21
SpringWorks Therapeutics, Inc.
$21
bluebird bio, Inc.
$20
Kyowa Kirin, Inc.
$15
CTI BioPharma Corp.
$15
Puma Biotechnology, Inc.
$15
Spectrum Pharmaceuticals Inc.
$15
Welch Allyn
$15
Helsinn Therapeutics (U.S.), Inc.
$14
Dova Pharmaceuticals
$14
Aurobindo Pharma USA, Inc.
$14
Pharmacyclics LLC, an AbbVie Company
$13
AbbVie, Inc.
$13
Baxter Healthcare
$13
Heron Therapeutics, Inc.
$13
Sun Pharmaceutical Industries Inc.
$13
PORTOLA PHARMACEUTICALS, INC.
$12
GlaxoSmithKline, LLC.
$11
Top 3 companies account for 69.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ADSTILADRIN · AFINITOR · AKYNZEO · ALUNBRIG · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BAVENCIO · BEVYXXA · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · CHANTIX · COSELA · CREON · CYRAMZA · Cabometyx · Columvi · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erivedge · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INTERSTIM · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYFGENIA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · Marqibo · NINLARO · Nerlynx · None · Nplate · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PEMAZYRE · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pomalyst · REBLOZYL · RYDAPT · Revlimid · SANDOSTATIN · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUSTOL · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TRULANCE · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tibsovo · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · Vanflyta · Venclexta · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xofigo · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for hematology & oncology in NJ.
Geographic Context
Hematology & oncology specialists within 10 mi
602
Per 100K population
105.1
County median income
$100,117
Nearest hospital
OVERLOOK MEDICAL CENTER
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Khot is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of NJ peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Khot experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Khot performed 566 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Khot receive payments from pharmaceutical companies?
Yes. Dr. Khot received a total of $77,093 from 82 companies across 657 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Khot's costs compare to other hematology & oncology specialists in Springfield?
Dr. Khot's average Medicare payment per service is $109. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Khot) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Springfield
Browse hematology & oncology specialists in Springfield ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Exelixis Inc. Payments to Doctors
See all physicians who received payments from Exelixis Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Merck Sharp & Dohme LLC Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology